These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3240703)

  • 1. Antitumour activity of new semi-synthetic anthracyclines containing fluorotalopyranose.
    Umezawa K; Takeuchi T; Komuro K; Nosaka C; Kunimoto S; Tsuchiya T; Takagi Y; Umezawa S; Umezawa H
    Drugs Exp Clin Res; 1988; 14(7):429-34. PubMed ID: 3240703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-alpha-L-talopyranosyl]- daunomycinone and -adriamycinone.
    Nakai K; Takagi Y; Tsuchiya T
    Carbohydr Res; 1999 Mar; 316(1-4):47-57. PubMed ID: 10420587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Ok K; Takagi Y; Tsuchiya T; Umezawa S; Umezawa H
    Carbohydr Res; 1987 Nov; 169():69-81. PubMed ID: 3427590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses and antitumor activities of 7-O-(3-amino-2,3,6-trideoxy-2-fluoro-alpha-L-talopyranosyl)daunomvcinone and -adriamycinone.
    Takagi Y; Park H; Tsuchiya T; Umezawa S; Takeuchi T; Komuro K; Nosaka C
    J Antibiot (Tokyo); 1989 Aug; 42(8):1315-7. PubMed ID: 2759914
    [No Abstract]   [Full Text] [Related]  

  • 5. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological properties of ME2303 (FAD-104), a new anthracycline.
    Omoto S; Kondo S; Fukatsu S; Takeuchi T; Umezawa K; Tsuchiya T; Umezawa S
    Drugs Exp Clin Res; 1988; 14(7):435-9. PubMed ID: 3240704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activities of new anthracyclines containing fluorine, FAD104 and its metabolites.
    Kunimoto S; Komuro K; Nosaka C; Tsuchiya T; Fukatsu S; Takeuchi T
    J Antibiot (Tokyo); 1990 May; 43(5):556-65. PubMed ID: 1694165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K; Kunimoto S; Takeuchi T
    Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.
    Israel M; Modest EJ; Frei E
    Cancer Res; 1975 May; 35(5):1365-8. PubMed ID: 1054622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses and antitumor activities of 7-O-(6-deoxy-2-O-methyl-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Takagi Y; Kobayashi N; Tsuchiya T; Umezawa S; Takeuchi T; Komuro K; Nosaka C
    J Antibiot (Tokyo); 1989 Aug; 42(8):1318-20. PubMed ID: 2759915
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitory activity of four demethoxy fluorinated anthracycline analogs against five human-tumor cell lines.
    Horton D; Khare A
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6179-81. PubMed ID: 20850305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumour activity of new daunorubicin and adriamycin analogues.
    Arcamone F; Bernardi L; Patelli B; Giardino P; Di Marco A; Casazza AM; Soranzo C; Pratesi G
    Experientia; 1978 Oct; 34(10):1255-7. PubMed ID: 570116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
    Dawson KM
    Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Apr; 42(4):1462-7. PubMed ID: 7060020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.
    Hisamatsu T; Suzuki K; Sakakibara S; Komuro K; Nagasawa M; Takeuchi T; Umezawa H
    Jpn J Cancer Res; 1985 Oct; 76(10):1008-20. PubMed ID: 3935619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New anthracycline glycosides obtained by the nitrous acid deamination of daunorubicin, doxorubicin and their configurational analogues.
    Cassinelli G; Ballabio M; Arcamone F; Casazza AM; Podesta' A
    J Antibiot (Tokyo); 1985 Jul; 38(7):856-67. PubMed ID: 3861603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
    Stefańska B; Dzieduszycka M; Bontemps-Gracz M; Borowski E; Martelli S
    J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adriamycin analogues. Preparation and biological evaluation of some N-perfluoroacyl analogues of daunorubicin, adriamycin, and N-(trifluoroacetyl)adriamycin 14-valerate and their 9,10-anhydro derivatives.
    Israel M; Potti G
    J Med Chem; 1982 Feb; 25(2):187-91. PubMed ID: 7057426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses and antitumor activities of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Tsuchiya T; Takagi Y; Ok K; Umezawa S; Takeuchi T; Wako N; Umezawa H
    J Antibiot (Tokyo); 1986 May; 39(5):731-3. PubMed ID: 3733524
    [No Abstract]   [Full Text] [Related]  

  • 20. Tetrahydropyranyl derivatives of daunomycin and adriamycin.
    Umezawa H; Takahashi Y; Kinoshita M; Naganawa H; Masuda T; Ishizuka M; Tatsuta K; Takeuchi T
    J Antibiot (Tokyo); 1979 Oct; 32(10):1082-4. PubMed ID: 528373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.